Evelyne Lopez-Crapez Selected Research

Biological Factors

1/2019

The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Evelyne Lopez-Crapez Research Topics

Disease

19	Neoplasms (Cancer) 02/2021 - 03/2006
11	Breast Neoplasms (Breast Cancer) 01/2020 - 03/2009
10	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 03/2009
4	Triple Negative Breast Neoplasms 10/2022 - 01/2011
4	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2011
3	Rectal Neoplasms (Rectal Cancer) 01/2017 - 07/2007
2	Adenocarcinoma 01/2021 - 05/2012
2	Brain Neoplasms (Brain Tumor) 01/2019 - 11/2016
1	Carcinoma (Carcinomatosis) 10/2023
1	Carcinogenesis 09/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Circulating Neoplastic Cells 01/2020
1	Microsatellite Instability 08/2016
1	Familial Breast Cancer 11/2013
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 03/2009
1	Disease Progression 03/2009

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 10/2022 - 03/2006
6	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2013
5	DNA (Deoxyribonucleic Acid)IBA 04/2014 - 03/2006
4	Cetuximab (Erbitux)FDA Link 01/2024 - 03/2009
3	ErbB Receptors (EGF Receptor)IBA 05/2012 - 01/2011
2	Trastuzumab (Herceptin)FDA Link 01/2021 - 03/2009
2	Irinotecan (Camptosar)FDA LinkGeneric 12/2020 - 03/2009
2	Messenger RNA (mRNA)IBA 01/2017 - 06/2011
2	Protein Isoforms (Isoforms)IBA 01/2017 - 01/2017
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2016 - 01/2016
2	Cell-Free Nucleic AcidsIBA 04/2014 - 06/2013
2	Hormones (Hormone)IBA 11/2013 - 01/2011
1	PlatinumIBA 10/2023
1	folfirinoxIBA 01/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	Nuclear Receptor Interacting Protein 1IBA 09/2021
1	Transcription Factors (Transcription Factor)IBA 09/2021
1	Gemcitabine FDA Link 01/2021
1	Alpha-Ketoglutarate-Dependent Dioxygenase FTOIBA 01/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 12/2020
1	BRCA1 ProteinIBA 03/2020
1	B7-H1 AntigenIBA 03/2020
1	Interleukin-8 (Interleukin 8)IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	LigandsIBA 01/2020
1	Adenosine (Adenocard)FDA LinkGeneric 01/2020
1	Circulating Tumor DNAIBA 10/2019
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2019
1	Blood Proteins (Serum Proteins)IBA 01/2019
1	Biological FactorsIBA 01/2019
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 02/2016
1	ElementsIBA 02/2016
1	AntigensIBA 01/2016
1	Tumor Biomarkers (Tumor Markers)IBA 01/2016
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2016
1	Carcinoembryonic AntigenIBA 01/2016
1	Plasminogen Activator Inhibitor 1IBA 11/2013
1	Tumor Suppressor p53-Binding Protein 1IBA 11/2013
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2013
1	Formaldehyde (Formol)FDA Link 01/2013
1	Fixatives (Pickling Agents)IBA 01/2013
1	Monoclonal AntibodiesIBA 05/2012
1	Phosphotransferases (Kinase)IBA 01/2012
1	tyrosine receptor (receptor, tyrosine)IBA 01/2012
1	Epidermal Growth Factor (EGF)IBA 01/2011
1	Fc gamma receptor IIAIBA 03/2009
1	Rituximab (Mabthera)FDA Link 03/2009
1	Growth Factor ReceptorsIBA 03/2009
1	Nuclear Proteins (Protein, Nuclear)IBA 07/2007
1	Codon (Codons)IBA 03/2006

Therapy/Procedure

8	Therapeutics 01/2022 - 01/2011
5	Drug Therapy (Chemotherapy) 01/2024 - 01/2016
2	Immunotherapy 10/2022 - 01/2020
2	Adjuvant Chemotherapy 02/2021 - 03/2020
2	Neoadjuvant Therapy 05/2012 - 07/2007
1	Precision Medicine 04/2014
1	Chemoradiotherapy 05/2012